Marex Group (MRX) Investor Day 2025 summary

Strategic direction and business model

• Maintains a consistent strategy since IPO, focusing on scalable, diversified, and resilient growth through organic expansion, selective M&A, product diversification, and global reach.

• Outperformed expectations in 2024 with faster market share gains, improved brand recognition, and large client mandate wins, benefiting from secular trends and macroeconomic volatility.

• Operates as a critical connector in the financial ecosystem, providing clearing, agency/execution, market making, and solutions, with strong cross-sell and risk management benefits.

• Competitive intensity has declined, with high barriers to entry from technology, compliance, and regulatory expertise, and a top-10 FCM position in the US.

• Focused on adding clients and increasing wallet share, with nearly 270 clients generating over $1 million each annually and ongoing global expansion.

Financial performance and guidance

• Achieved 28% revenue growth in 2024 to $1.6bn, with profit up 40% to $321m, margin expansion to 20%, and return on equity reaching 30% (excluding IPO expenses).

• Q1 2025 revenues up 25% YoY to $449–464m, profit up 39–40% YoY to $92–97m, and margin at 21%, with continued strong momentum.

• Over 75% of recent growth has been organic, but expects inorganic growth to rise to 40% over the next five years, targeting a 60/40 organic/inorganic mix.

• Targets 10–20% annual profit growth and mid-20% margin over the next five years, aiming for $500–$800 million profit by 2029.

• Maintains strong capital position, low leverage, investment-grade ratings, and a progressive dividend policy supporting disciplined M&A and shareholder returns.

Business segment and product highlights

• Clearing: Largest profit contributor, $460 million in 2024 revenue, 1.1bn contracts cleared, $13 billion in client balances, and top-10 FCM status in the US.

• Agency & Execution: Largest revenue segment, $700 million in 2024, 54–55% CAGR (2021–2024), margin improvement to 19%, and increased cross-selling.

• Market Making: $200 million in 2024 revenue, $66 million PBT, 14% CAGR (2021–2024), 35% margin, and 98% positive trading weeks across 39 asset classes.

• Solutions: $162 million in 2024 revenue, 26% margin, 36% CAGR (2020–2024), specializing in customized derivatives and structured products.

• Significant investments in technology, automation, and risk management underpin operational efficiency and scalability.